Eris Lifesciences has announced a board meeting scheduled for February 13, 2026, to review and approve the standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2025. The trading window, already closed since January 1, 2026, will remain shut until 48 hours after the results are declared.
Board Meeting Announcement
A meeting of the Board of Directors of Eris Lifesciences Limited is scheduled for Friday, February 13, 2026. The primary agenda is to consider and approve the standalone and consolidated unaudited financial results for the quarter and nine months ending December 31, 2025.
Trading Window Closure
The trading window for dealing in the company’s securities, which has been closed since January 01, 2026, will remain closed until 48 hours after the declaration of the financial results. This closure is in accordance with the company’s policies and the applicable regulations regarding insider trading.
Source: BSE
